Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Mishto

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Proteomics|June 14, 2020
What We See, What We Do Not See, and What We Do Not Want to See in HLA Class I ImmunopeptidomesMichele Mishto
Molecular & Cellular Proteomics : MCP|October 4, 2021
Commentary: Are There Indeed Spliced Peptides in the Immunopeptidome?Michele Mishto
Trends in Immunology|August 24, 2017
Post-Translational Peptide Splicing and T Cell ResponsesMichele Mishto, Juliane Liepe
Current Opinion in Immunology|May 4, 2018
Why do proteases mess up with antigen presentation by re-shuffling antigen sequences?Juliane Liepe, Huib Ovaa, Michele Mishto
Immunology Letters|July 17, 2024
Proteasome isoforms in human thymi and mouse modelsMichele Mishto, Iina Takala, Paola Bonfanti, et al.
Frontiers in Immunology|May 3, 2021
Potential Mimicry of Viral and Pancreatic β Cell Antigens Through Non-Spliced and <i>cis</i>-Spliced <i>Zwitter</i> Epitope Candidates in Type 1 DiabetesMichele Mishto, Artem Mansurkhodzhaev, Teresa Rodriguez-Calvo, et al.
Proteomics|October 3, 2022
iBench: A ground truth approach for advanced validation of mass spectrometry identification methodJohn A Cormican, Wai Tuck Soh, Michele Mishto, et al.
Frontiers in Immunology|March 15, 2021
Proteasome-Generated <i>cis</i>-Spliced Peptides and Their Potential Role in CD8<sup>+</sup> T Cell ToleranceArtem Mansurkhodzhaev, Camila R R Barbosa, Michele Mishto, et al.
European Journal of Immunology|July 9, 2025
nuTCRacker: Predicting the Recognition of HLA-I-Peptide Complexes by αβTCRs for Unseen PeptidesJustin Barton, Trupti Gore, Meghna Phanichkrivalkosil, et al.
Frontiers in Immunology|July 30, 2021
Response: Commentary: An <i>In Silico-In Vitro</i> Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer PatientsMichele Mishto, Guillermo Rodriguez-Hernandez, Jacques Neefjes, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Proteomics|June 14, 2020
What We See, What We Do Not See, and What We Do Not Want to See in HLA Class I ImmunopeptidomesMichele Mishto
Molecular & Cellular Proteomics : MCP|October 4, 2021
Commentary: Are There Indeed Spliced Peptides in the Immunopeptidome?Michele Mishto
Trends in Immunology|August 24, 2017
Post-Translational Peptide Splicing and T Cell ResponsesMichele Mishto, Juliane Liepe
Current Opinion in Immunology|May 4, 2018
Why do proteases mess up with antigen presentation by re-shuffling antigen sequences?Juliane Liepe, Huib Ovaa, Michele Mishto
Immunology Letters|July 17, 2024
Proteasome isoforms in human thymi and mouse modelsMichele Mishto, Iina Takala, Paola Bonfanti, et al.
Frontiers in Immunology|May 3, 2021
Potential Mimicry of Viral and Pancreatic β Cell Antigens Through Non-Spliced and <i>cis</i>-Spliced <i>Zwitter</i> Epitope Candidates in Type 1 DiabetesMichele Mishto, Artem Mansurkhodzhaev, Teresa Rodriguez-Calvo, et al.
Proteomics|October 3, 2022
iBench: A ground truth approach for advanced validation of mass spectrometry identification methodJohn A Cormican, Wai Tuck Soh, Michele Mishto, et al.
Frontiers in Immunology|March 15, 2021
Proteasome-Generated <i>cis</i>-Spliced Peptides and Their Potential Role in CD8<sup>+</sup> T Cell ToleranceArtem Mansurkhodzhaev, Camila R R Barbosa, Michele Mishto, et al.
European Journal of Immunology|July 9, 2025
nuTCRacker: Predicting the Recognition of HLA-I-Peptide Complexes by αβTCRs for Unseen PeptidesJustin Barton, Trupti Gore, Meghna Phanichkrivalkosil, et al.
Frontiers in Immunology|July 30, 2021
Response: Commentary: An <i>In Silico-In Vitro</i> Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer PatientsMichele Mishto, Guillermo Rodriguez-Hernandez, Jacques Neefjes, et al.
Pageof 7